|
Delayed
Japan Exchange
10:30:00 10/11/2026 +04
|
5-day change | 1st Jan Change | ||
| 1,748.00 JPY | +8.37% |
|
-21.58% | -32.54% |
| 11-04 | Organo Corporation Reports Earnings Results for the Half Year Ended September 30, 2026 | CI |
| 08-03 | Organo Corporation Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
Company Valuation: Organo Corporation
Data adjusted to current consolidation scope
| Fiscal Period: March | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 116,036 | 165,430 | 353,770 | 292,805 | 625,823 | 402,017 | - | - |
| Change | - | 42.57% | 113.85% | -17.23% | 113.73% | -35.76% | - | - |
| Enterprise Value (EV) 1 | 111,466 | 182,891 | 372,593 | 298,611 | 629,170 | 402,005 | 383,947 | 349,100 |
| Change | - | 64.08% | 103.72% | -19.86% | 110.7% | -36.11% | -4.49% | -9.08% |
| P/E | 12.6x | 14.1x | 20.4x | 12.1x | 22x | 13.5x | 11.3x | 10.3x |
| PBR | 1.53x | 1.92x | 3.47x | 2.42x | 4.38x | 2.44x | 2.19x | 1.91x |
| PEG | - | 0.5x | 0.4x | 0.3x | 1.3x | 2.98x | 0.6x | 1.14x |
| Capitalization / Revenue | 1.04x | 1.25x | 2.35x | 1.79x | 3.52x | 1.96x | 1.71x | 1.56x |
| EV / Revenue | 0.99x | 1.38x | 2.48x | 1.83x | 3.54x | 1.96x | 1.63x | 1.35x |
| EV / EBITDA | - | 10.7x | 15.2x | 9.04x | 15.9x | 9.57x | 7.39x | 6.21x |
| EV / EBIT | 10.3x | 12x | 16.5x | 9.6x | 16.7x | 9.8x | 8x | 6.67x |
| EV / FCF | 15.1x | -9.14x | 161x | 16.3x | 65.7x | 14.9x | 15.4x | 16.4x |
| FCF Yield | 6.64% | -10.9% | 0.62% | 6.13% | 1.52% | 6.73% | 6.51% | 6.12% |
| Dividend per Share 2 | 8 | 12.4 | 20.4 | 32 | 40 | 48 | 50 | 52.67 |
| Rate of return | 1.58% | 1.72% | 1.32% | 2.51% | 1.47% | 2.75% | 2.86% | 3.01% |
| EPS 2 | 40.13 | 51.15 | 75.38 | 105.1 | 123.5 | 129.1 | 155.3 | 169.3 |
| Distribution rate | 19.9% | 24.2% | 27.1% | 30.5% | 32.4% | 37.2% | 32.2% | 31.1% |
| Net sales 1 | 112,069 | 132,426 | 150,356 | 163,269 | 177,654 | 205,000 | 235,333 | 258,000 |
| EBITDA 1 | - | 17,036 | 24,554 | 33,045 | 39,629 | 42,000 | 51,950 | 56,250 |
| EBIT 1 | 10,850 | 15,212 | 22,544 | 31,120 | 37,648 | 41,000 | 48,000 | 52,333 |
| Net income 1 | 9,210 | 11,730 | 17,310 | 24,150 | 28,401 | 30,567 | 35,700 | 38,933 |
| Net Debt 1 | -4,570 | 17,461 | 18,823 | 5,806 | 3,347 | -11.71 | -18,070 | -52,917 |
| Reference price 2 | 506.50 | 721.00 | 1,540.00 | 1,274.00 | 2,722.00 | 1,748.00 | 1,748.00 | 1,748.00 |
| Nbr of stocks (in thousands) | 229,094 | 229,445 | 229,721 | 229,831 | 229,913 | 229,987 | - | - |
| Announcement Date | 12/05/22 | 12/05/23 | 13/05/24 | 13/05/25 | 13/05/26 | - | - | - |
1JPY in Million2JPY
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 12.49x | 1.81x | 8.83x | 2.98% | 2.35B | ||
| 29.94x | 4.42x | 14.32x | 1.6% | 94.08B | ||
| 33.97x | 5.09x | 15.96x | 1.04% | 75.18B | ||
| 40.69x | 5.62x | 16.93x | 0.75% | 47.54B | ||
| 28.5x | 5x | 19.4x | 0.44% | 28.71B | ||
| -66.98x | 4.88x | 15.79x | 0.11% | 20B | ||
| 27.26x | 2.66x | 12.27x | -.--% | 15.17B | ||
| 25.33x | - | - | 0.56% | 10.52B | ||
| 20.47x | 2.69x | 13.48x | 1.46% | 10.22B | ||
| 1942.71x | 3.61x | 15.83x | -.--% | 6.3B | ||
| Average | 209.44x | 3.98x | 14.76x | 0.89% | 31B | |
| Weighted average by Cap. | 64.32x | 4.68x | 15.59x | 0.99% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- 6368 Stock
- Valuation Organo Corporation
Select your edition
All financial news and data tailored to specific country editions
















